The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 19, 2026
Snapshot (as of Oct 19, 2026): Roche Holding AG (RHHBF) pays a $9.80 annual dividend, yielding 2.71% at $458.47/share. Next ex-dividend date 2026-03-12. 9 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.71%
Annual Dividend: $9.80 per share
Payout Ratio: 63.9%
Ex-Dividend Date: 2026-03-12
Dividend Frequency: annually
Sector: Healthcare
Years of Dividend History: 25
Roche Holding AG dividend investors are looking at a global pharmaceutical and diagnostics company founded in 1896, with operations spanning oncology, neurology, infectious disease, and in vitro diagnostics across dozens of countries. The current yield stands at 2.73%, with a trailing annual dividend rate of $9.80 per share paid annually. The next ex-dividend date is March 13, 2026. A beta of 0.347 points to low price volatility, which suits income investors who prioritize capital preservation alongside a steady annual payout.
Roche Holding AG pays out 68.5% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a broad product base spanning cancer therapies, treatments for neurological and immunological conditions, and a diagnostics division that generates demand for in vitro tests across diseases including cancer, diabetes, and hepatitis. Roche Holding AG dividend safety faces its main pressure from that payout ratio itself: at 68.5%, there is limited room to absorb an earnings decline before the dividend would require adjustment.
Roche Holding AG dividend history shows a CAGR of 3.2% per year from 2011 to 2025. Per-share payments grew from $7.09 to $10.97 over that window (the 2026 figure of $12.41 reflects a partial year and is excluded from the CAGR). The largest annual increase in the window was 19.6% in 2014, though the history also contains at least one year-over-year decline exceeding 5%, so growth has not been linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +3.5% | $9.89 (2022) | $10.97 (2025) |
| 5-Year | +3.4% | $9.29 (2020) | $10.97 (2025) |
| 10-Year | +2.8% | $8.31 (2015) | $10.97 (2025) |
RHHBF stock fits dividend investors who want moderate, recurring income from a large, diversified healthcare business rather than aggressive payout growth. The yield of 2.73% sits in the moderate (2–4%) range and is above the stock's own 5-year average of 2.33%, which means the current entry point delivers more income than the historical norm. Growth has averaged 3.2% annually over 14 years. That pace is slow, and the 68.5% payout ratio leaves limited headroom. What an investor gets is a low-volatility stock with nine consecutive years of dividend increases and a yield that currently exceeds its own historical average.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-13 | $12.4084 |
| 2025-03-28 | $10.9720 |
| 2024-03-14 | $10.9260 |
| 2023-03-16 | $10.1840 |
| 2022-03-17 | $9.8880 |
| 2021-03-18 | $9.8700 |
| 2020-03-19 | $9.2950 |
| 2019-03-07 | $8.6580 |
| 2018-03-15 | $8.7840 |
| 2017-03-16 | $8.1980 |
| Year | Total Dividends |
|---|---|
| 2026 | $12.4084 |
| 2025 | $10.9720 |
| 2024 | $10.9260 |
| 2023 | $10.1840 |
| 2022 | $9.8880 |
Project income from RHHBF with the RHHBF dividend calculator or track your full portfolio with the dividend tracker.